Bir Dawn Carter
Insider CIK 1688712 · SAVA Director · RETA VP, Chief Commercial Officer · SLNO Director · GERN Interim President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GERN GERON CORP | A Award deriv | 2026-05-20 | 2026-05-26 | 220,000 | — | $0 | 220,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | D To issuer | 2026-05-18 | 2026-05-18 | 16,991 | — | $0 | 0 | SEC↗ |
| SAVA CASSAVA SCIENCES INC | A Award deriv | 2025-10-21 | 2025-10-22 | 53,000 | — | $0 | 53,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2025-06-05 | 2025-06-09 | 3,991 | — | $0 | 16,991 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2025-05-21 | 2025-05-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2024-08-15 | 2024-08-16 | 13,000 | — | $0 | 13,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2024-05-09 | 2024-05-10 | 180,000 | — | $0 | 180,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 34,500 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 16,500 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 70,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 63,650 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 71,300 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 17,250 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 17,250 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer deriv | 2023-09-26 | 2023-09-26 | 24,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | D To issuer | 2023-09-26 | 2023-09-26 | 33,805 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-08-16 | 2023-08-17 | 398 | $168.33 | $67.0K | 33,805 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-08-15 | 2023-08-17 | 807 | $169.04 | $136.4K | 34,203 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2023-07-28 | 2023-08-01 | 40,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 40,000 | $22.57 | $902.8K | 40,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-07-28 | 2023-08-01 | 40,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2023-07-28 | 2023-08-01 | 40,000 | — | $0 | 75,010 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-07-28 | 2023-08-01 | 40,000 | $164.54 | $6.58M | 35,010 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-07-06 | 2023-07-10 | 4,125 | — | $0 | 35,010 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2023-05-31 | 2023-06-02 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-05-16 | 2023-05-17 | 417 | $80.96 | $33.8K | 30,885 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-05-15 | 2023-05-17 | 894 | $85.09 | $76.1K | 31,302 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-13 | 2023-03-15 | 9,317 | $86.77 | $808.4K | 32,196 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-07 | 2023-03-08 | 41,630 | $21.05 | $876.3K | 41,630 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-07 | 2023-03-08 | 41,630 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2023-03-07 | 2023-03-08 | 41,630 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2023-03-07 | 2023-03-08 | 41,630 | — | $0 | 83,555 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-07 | 2023-03-08 | 36,049 | $85.08 | $3.07M | 47,506 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-07 | 2023-03-08 | 5,793 | $85.90 | $497.6K | 41,713 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-07 | 2023-03-08 | 200 | $86.67 | $17.3K | 41,513 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2023-03-06 | 2023-03-08 | 48,370 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-06 | 2023-03-08 | 48,370 | — | $0 | 41,630 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-06 | 2023-03-08 | 48,370 | $21.05 | $1.02M | 48,370 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-06 | 2023-03-08 | 14,820 | $90.26 | $1.34M | 41,925 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2023-03-06 | 2023-03-08 | 48,370 | — | $0 | 96,879 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-06 | 2023-03-08 | 40,134 | $89.30 | $3.58M | 56,745 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2023-03-03 | 2023-03-06 | 2,166 | $88.25 | $191.1K | 48,509 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2023-01-03 | 2023-01-04 | 63,650 | — | $0 | 63,650 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2023-01-03 | 2023-01-04 | 15,675 | — | $0 | 50,675 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2022-05-10 | 2022-05-11 | 125,000 | — | $0 | 125,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2022-01-03 | 2022-01-05 | 70,000 | — | $0 | 70,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award | 2022-01-03 | 2022-01-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2021-05-11 | 2021-05-13 | 83,000 | — | $0 | 83,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2021-01-04 | 2021-01-06 | 16,500 | — | $0 | 16,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 60,000 | $21.05 | $1.26M | 60,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | M Exercise deriv | 2020-11-09 | 2020-11-10 | 60,000 | — | $0 | 90,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion deriv | 2020-11-09 | 2020-11-10 | 60,000 | — | $0 | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-09 | 2020-11-10 | 30,000 | $175.00 | $5.25M | 0 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | S Sale | 2020-11-09 | 2020-11-10 | 30,000 | $150.01 | $4.50M | 30,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | C Conversion | 2020-11-09 | 2020-11-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2020-06-05 | 2020-06-09 | 83,000 | — | $0 | 83,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2020-01-02 | 2020-01-06 | 24,000 | — | $0 | 24,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-11-11 | 2019-11-12 | 17,250 | — | $0 | 17,250 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-10-14 | 2019-11-12 | 17,250 | — | $0 | 17,250 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2019-06-06 | 2019-06-07 | 70,000 | — | $0 | 70,000 | SEC↗ |
| GERN GERON CORP | A Award deriv | 2019-03-26 | 2019-03-28 | 120,000 | — | $0 | 120,000 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2019-01-02 | 2019-01-03 | 34,500 | — | $0 | 34,500 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2017-12-06 | 2017-12-07 | 71,300 | — | $0 | 71,300 | SEC↗ |
| RETA REATA PHARMACEUTICALS INC | A Award deriv | 2016-12-07 | 2016-12-08 | 40,000 | — | $0 | 40,000 | SEC↗ |